PT - JOURNAL ARTICLE AU - Tamar Amitai AU - Yoav Kan-Tor AU - Naama Srebnik AU - Amnon Buxboim TI - Embryo classification beyond pregnancy: Early prediction of first trimester miscarriage using machine learning AID - 10.1101/2020.11.24.20237610 DP - 2020 Jan 01 TA - medRxiv PG - 2020.11.24.20237610 4099 - http://medrxiv.org/content/early/2020/11/24/2020.11.24.20237610.short 4100 - http://medrxiv.org/content/early/2020/11/24/2020.11.24.20237610.full AB - Objective Develop a machine learning classifier for predicting the risk of cleavage-stage embryos to undergo first trimester miscarriage based on time-lapse images of preimplantation development.Design Retrospective study of a 4-year multi-center cohort of women undergoing intra-cytoplasmatic sperm injection (ICSI). The study included embryos with positive indication of clinical implantation based on gestational sac visualization either with first trimester miscarriage or live birth outcome. Miscarriage was determined based on negative fetal heartbeat indication during the first trimester.Setting Data were recorded and obtained in hospital setting and research was performed in university setting.Patient(s) Data from 391 women who underwent fresh single or double embryo transfers were included.Intervention(s) None.Main Outcome Measure(s) A minimal subset of six non-redundant morphodynamic features were screened that maintain high prediction capacity. Using this feature subset, XGBoost and Random Forest models were trained following a 100-fold Monte-Carlo cross validation scheme. Feature importance was scored using the SHapley Additive exPlanations (SHAP) methodology. Miscarriage versus live-birth outcome prediction was evaluated using a non-contaminated balanced test set and quantified in terms of the area under the receiver operating characteristic (ROC) curve (AUC), precision-recall curve, positive predictive value (PPV), and confusion matrices.Result(s) Features that account for the distribution of the nucleolus precursor bodies within the small pronucleus and pronuclei dynamics were highly predictive of miscarriage outcome. AUC for miscarriage prediction of validation and test set embryos using both models was 0.68-to-0.69. Clinical utility was tested by setting two classification thresholds accounting for high sensitivity 0.73 with 0.6 specificity and high specificity 0.93 with 0.33 sensitivity.Conclusion(s) We report the development of a decision-support tool for identifying the embryos with high risk of miscarriage. Prioritizing embryos for transfer based on their predicted risk of miscarriage in combination with their predicted implantation potential will improve live-birth rates and shorten time-to-pregnancy.Capsule The risk of first trimester miscarriage of cleavage stage embryos is predicted with AUC 68% by screening a minimal subset of six non-redundant morpho-dynamic features and training a machine-learning classifier.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe greatly appreciate support from the European Research Council (ERC-StG 678977). No third party support was provided.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Hadassah Hebrew University Medical center IRB number HMO 558-14; Kaplan Medical Center IRB 0040-16-KMC; Soroka Medical Center IRB 0328-17-SOR; Rabin Medical Center IRB 0767-15-RMC.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to ethical considerations and regulations by the Israeli Ministry of Health, no access is granted here to the data.